Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 173.45 Billion JPY | 4.33% |
| 2022 | 166.25 Billion JPY | 7.09% |
| 2021 | 155.25 Billion JPY | 3.15% |
| 2020 | 150.51 Billion JPY | -10.44% |
| 2019 | 168.05 Billion JPY | 0.34% |
| 2018 | 167.47 Billion JPY | 6.84% |
| 2017 | 156.76 Billion JPY | 2.69% |
| 2016 | 152.65 Billion JPY | 11.25% |
| 2015 | 137.21 Billion JPY | 6.91% |
| 2014 | 128.34 Billion JPY | 0.83% |
| 2013 | 127.29 Billion JPY | 4.74% |
| 2012 | 121.53 Billion JPY | -7.34% |
| 2011 | 131.16 Billion JPY | 0.49% |
| 2010 | 130.52 Billion JPY | 1.12% |
| 2009 | 129.08 Billion JPY | 2.82% |
| 2008 | 125.54 Billion JPY | -44.97% |
| 2007 | 228.13 Billion JPY | -11.41% |
| 2006 | 257.5 Billion JPY | 4.11% |
| 2005 | 247.33 Billion JPY | 14.48% |
| 2004 | 216.05 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 36.48 Billion JPY | -32.86% |
| 2024 Q2 | 36.65 Billion JPY | 0.45% |
| 2023 Q2 | 40.15 Billion JPY | 19.99% |
| 2023 FY | 173.45 Billion JPY | 4.33% |
| 2023 Q3 | 45.49 Billion JPY | 13.28% |
| 2023 Q4 | 54.34 Billion JPY | 19.45% |
| 2023 Q1 | 33.46 Billion JPY | -35.61% |
| 2022 FY | 166.25 Billion JPY | 7.09% |
| 2022 Q2 | 38.61 Billion JPY | 18.29% |
| 2022 Q1 | 32.64 Billion JPY | -31.41% |
| 2022 Q4 | 51.97 Billion JPY | 20.84% |
| 2022 Q3 | 43.01 Billion JPY | 11.39% |
| 2021 FY | 155.25 Billion JPY | 3.15% |
| 2021 Q4 | 47.59 Billion JPY | 17.21% |
| 2021 Q1 | 30.26 Billion JPY | -33.42% |
| 2021 Q2 | 36.78 Billion JPY | 21.52% |
| 2021 Q3 | 40.6 Billion JPY | 10.39% |
| 2020 FY | 150.51 Billion JPY | -10.44% |
| 2020 Q4 | 45.46 Billion JPY | 16.97% |
| 2020 Q3 | 38.86 Billion JPY | 13.42% |
| 2020 Q2 | 34.26 Billion JPY | 7.39% |
| 2020 Q1 | 31.91 Billion JPY | -36.51% |
| 2019 FY | 168.05 Billion JPY | 0.34% |
| 2019 Q4 | 50.26 Billion JPY | 13.82% |
| 2019 Q3 | 44.15 Billion JPY | 10.69% |
| 2019 Q2 | 39.89 Billion JPY | 18.26% |
| 2019 Q1 | 33.73 Billion JPY | -34.76% |
| 2018 Q1 | 33.71 Billion JPY | -31.35% |
| 2018 Q2 | 38.96 Billion JPY | 15.57% |
| 2018 FY | 167.47 Billion JPY | 6.84% |
| 2018 Q4 | 51.71 Billion JPY | 20.01% |
| 2018 Q3 | 43.09 Billion JPY | 10.59% |
| 2017 Q4 | 49.1 Billion JPY | 21.72% |
| 2017 FY | 156.76 Billion JPY | 2.69% |
| 2017 Q1 | 30.74 Billion JPY | 0.0% |
| 2017 Q2 | 36.55 Billion JPY | 18.89% |
| 2017 Q3 | 40.34 Billion JPY | 10.36% |
| 2016 FY | 152.65 Billion JPY | 11.25% |
| 2016 Q2 | 36.76 Billion JPY | 12.77% |
| 2016 Q3 | 37.59 Billion JPY | 2.26% |
| 2016 Q1 | 32.6 Billion JPY | -20.56% |
| 2015 FY | 137.21 Billion JPY | 6.91% |
| 2015 Q1 | 31.19 Billion JPY | -19.25% |
| 2015 Q4 | 41.03 Billion JPY | 22.15% |
| 2015 Q2 | 29.97 Billion JPY | -3.91% |
| 2015 Q3 | 33.59 Billion JPY | 12.1% |
| 2014 Q4 | 38.62 Billion JPY | 23.18% |
| 2014 Q2 | 27.17 Billion JPY | -13.93% |
| 2014 FY | 128.34 Billion JPY | 0.83% |
| 2014 Q3 | 31.35 Billion JPY | 15.41% |
| 2014 Q1 | 31.56 Billion JPY | -15.77% |
| 2013 Q3 | 31.03 Billion JPY | 14.08% |
| 2013 Q4 | 37.47 Billion JPY | 20.75% |
| 2013 Q2 | 27.2 Billion JPY | 1.89% |
| 2013 Q1 | 26.7 Billion JPY | -26.99% |
| 2013 FY | 127.29 Billion JPY | 4.74% |
| 2012 Q1 | 28.43 Billion JPY | -26.56% |
| 2012 Q2 | 28.07 Billion JPY | -1.23% |
| 2012 Q4 | 36.57 Billion JPY | 21.21% |
| 2012 Q3 | 30.17 Billion JPY | 7.46% |
| 2012 FY | 121.53 Billion JPY | -7.34% |
| 2011 Q2 | 29.86 Billion JPY | 6.02% |
| 2011 Q4 | 38.71 Billion JPY | 13.34% |
| 2011 Q3 | 34.15 Billion JPY | 14.37% |
| 2011 FY | 131.16 Billion JPY | 0.49% |
| 2011 Q1 | 28.17 Billion JPY | -26.08% |
| 2010 Q1 | 26.76 Billion JPY | -30.6% |
| 2010 Q2 | 30.73 Billion JPY | 14.86% |
| 2010 Q3 | 33.51 Billion JPY | 9.02% |
| 2010 FY | 130.52 Billion JPY | 1.12% |
| 2010 Q4 | 38.1 Billion JPY | 13.72% |
| 2009 Q1 | 26.86 Billion JPY | -29.12% |
| 2009 Q3 | 33.18 Billion JPY | 8.55% |
| 2009 Q4 | 38.56 Billion JPY | 16.19% |
| 2009 FY | 129.08 Billion JPY | 2.82% |
| 2009 Q2 | 30.57 Billion JPY | 13.82% |
| 2008 Q4 | 37.89 Billion JPY | 17.35% |
| 2008 FY | 125.54 Billion JPY | -44.97% |
| 2008 Q3 | 32.29 Billion JPY | 0.0% |
| 2007 FY | 228.13 Billion JPY | -11.41% |
| 2006 FY | 257.5 Billion JPY | 4.11% |
| 2005 FY | 247.33 Billion JPY | 14.48% |
| 2004 FY | 216.05 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 117.4 Thousand USD | -147740626.545% |
| Bruush Oral Care Inc. | 2.63 Million USD | -6589029.029% |
| CCA Industries, Inc. | 10.48 Million USD | -1653960.126% |
| DSwiss, Inc. | 1.47 Million USD | -11798989.976% |
| EOS, Inc. | 296.85 Thousand USD | -58431374.27% |
| Greyson International, Inc. | 1684.10 USD | -10299566434.054% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -144545733.333% |
| Infusion Brands International, Inc. | 18.18 Million USD | -953791.391% |
| Mandom Corporation | 483.85 Million USD | -35748.888% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | - USD | -Infinity% |
| Oliveda International, Inc. | 3.86 Million USD | -4491603.73% |
| PacificHealth Laboratories, Inc. | 6.91 Million USD | -2508353.585% |
| Prosperous Future Holdings Limited | 66.24 Million USD | -261732.961% |
| PURE Bioscience, Inc. | 1.96 Million USD | -8836120.071% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 20 Thousand USD | -867274900.0% |
| Sentient Brands Holdings Inc. | 150.00 USD | -115636666566.667% |
| Sunset Capital Assets, Inc. | 12.39 Thousand USD | -1399733599.161% |
| The Stephan Co. | 10.58 Million USD | -1638896.504% |
| Turner Valley Oil & Gas, Inc. | 91.00 USD | -190609890009.89% |
| Winning Brands Corporation | 179.21 Thousand USD | -96788583.667% |
| Warpaint London PLC | 114.21 Million USD | -151773.318% |
| Zoono Group Limited | 647.07 Thousand USD | -26805870.242% |
| Zurvita Holdings, Inc. | 7.89 Million USD | -2197259.368% |